NHS
NICE Recommends Novartis' Tafinlar-Mekinist as Frontline Treatment for BRAF-Mutant NSCLC
The agency estimated that the drug combination's cost-effectiveness falls within what it considers an acceptable use of the NHS's resources.
NICE Backs Availability of Gilead's Yescarta, Tecartus Through Cancer Drugs Fund
The institute declined to recommend certain indications of the hematologic cancer drugs last year, but will collect additional data on their efficacy through the Cancer Drugs Fund.
UK National Health Service Rolls out Lynch Syndrome Genetic Testing
The new service will not only help guide patient treatment but also identify relatives who might be at higher risk of developing certain cancers.
Lung Function GWAS Meta-Analysis Yields Insights Into Healthy, Diseased States
A multi-ancestry meta-analysis revealed more than 550 lung function-related genes, along with genetic risk scores linked to several traits or conditions.
NHS Unveils New Cell and Gene Manufacturing Facility to Advance Research, Drug Development
The facility will provide researchers with viral vectors and plasmids to make cell and gene therapies at a clinical scale, reducing reliance on suppliers abroad.